We are proud to announce the selection of Dr. Reshma Ramracheya for an oral presentation at the prestigious Third European Association for the Study of Diabetes Incretin Study Group Meeting. Our Head of Pharmaceutical Operations will be discussing what is “known, new, controversial” in the incretin field so as to identify key questions that need to be addressed in clinical and fundamental science and propose key clinical trials.

Latest News
  • 17 September 2020 CIDP reinforces its team of Medical & Scientific writers!
  • 10 July 2020 Skin Penetration
  • 03 July 2020 Nutricosmetics clinical trials: CIDP provides the science and data to support a product’s touted properties!
Archives

Time Zone

Choose a centre